Study S001335

Tirzepatide for the Treatment of Alcohol Use Disorder: A Pilot Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06727331
Acronym: STREAM
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: RECRUITING
Enrollment: 20
Start: 2025-09-15
Primary completion: 2027-03-01
Lead sponsor: Brigham and Women's Hospital
Conditions: Alcohol Use Disorder (AUD)
Interventions: DRUG:Tirzepatide; OTHER:Saline Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Cue-induced Cravings for Alcohol [Baseline visit and 5 weeks after baseline visit.]
Incidence and Severity of Adverse Events [Epic monitoring throughout the trial and PRISE administered at study weeks 2-5 (visits 3-6).]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.